PRKN and Parkinson disease: Although quantitative changes in PARIS were reported in the substantia nigra (SN) of PD patients and several PD models, including conditional parkin knockout (KO) and α-synuclein preformed fibrils (α-syn PFFs)-injected mice [6,7,8,9], qualitative modifications of PARIS remain uncharacterized.